Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-29

Clinical Trial Update: Chinese PD-SNCA Registry

View source ↗

Summary

This entry reports that the PD-SNCA Registry trial in China is currently recruiting participants for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Parkinson Disease | Status: RECRUITING